UT-Battelle licenses tissue regeneration technologies to NellOne Therapeutics, Inc.
01-Feb-2010 -
In a major step toward commercialization of a promising therapeutic treatment, Oak Ridge National Laboratory contractor UT-Battelle has exclusively licensed patents on inventions based on the Nell-1 gene to NellOne Therapeutics, Inc., a company spun out of the Department of Energy ...
cell signaling
Formation
genetics
+5